Wake and light therapy for moderate-to-severe depression - a randomized controlled trial

Area of Science:

• Psychiatry
• Sleep Medicine
• Chronobiology

Background:

• Hospitalized patients with depression often experience disrupted sleep patterns and reduced self-efficacy.
• Standard depression treatments may benefit from adjunctive therapies targeting circadian rhythm regulation.

Purpose of the Study:

• To evaluate the efficacy of wake and light therapy as an adjunct to standard depression treatment for hospitalized patients.
• To assess the impact of the intervention on depressive symptoms, self-efficacy, and sleep patterns.

Main Methods:

• A randomized controlled trial involving 64 patients with moderate-to-severe depression.
• Intervention group received standard treatment plus three wake therapy sessions, daily 30-minute light treatment, and sleep time stabilization for nine weeks.
• Control group received standard treatment only.

Main Results:

• The wake therapy group showed a significant initial decrease in depressive symptoms (HAM-D17) in week one (P=0.04).
• No significant differences in depressive symptoms were observed between weeks two and nine.
• Significant improvements in general self-efficacy (P=0.001) and reduced nighttime awakenings (P=0.0008) were noted at week nine.
• Patients in the intervention group experienced less daytime sleep and shorter naps.

Conclusions:

• Wake and light therapy provided an initial antidepressant effect that was not sustained over the nine-week study period.
• The intervention led to significant long-term improvements in general self-efficacy and sleep quality.
• Adjunctive wake and light therapy may be a useful strategy for improving specific outcomes in hospitalized depression patients.